{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:01:59Z","timestamp":1785254519042,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.nefroe.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:00:04Z","timestamp":1711630804000},"page":"301-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD)"],"prefix":"10.1016","volume":"44","author":[{"given":"Iris","family":"Viejo Boyano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Jos\u00e9","family":"Hern\u00e1ndez Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Guti\u00e9rrez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2024.03.002_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nefro.2021.05.009","article-title":"Documento de consenso de poliquistosis renal autos\u00f3mica dominante. Revisi\u00f3n 2020","volume":"42","author":"Ars","year":"2021","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2016.06.017","article-title":"Gastrointestinal manifestations of autosomal-dominant polycystic kidney disease","volume":"15","author":"Mikolajczyk","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/jmg.27.10.603","article-title":"Map of 16 polymorphic loci on the short armo f chromosome 16 close to the polycystic kidney disease gene (PKD1)","volume":"27","author":"Breuning","year":"1990","journal-title":"J Med Genet"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1293-359","article-title":"Chromosome 4 localization of a second gen for autosomal dominant polycystic kidney disease","volume":"5","author":"Peters","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0030","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJ\u03b211 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec Le Gall","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0035","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2019030298","article-title":"ALG9 mutation carriers develop kidney and liver cysts","volume":"30","author":"Beese","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40620-021-01062-6","article-title":"Therapeutic advances in ADPKD: the future awaits","volume":"35","author":"Capuano","year":"2022","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefroe.2024.03.002_bib0045","unstructured":"Ministerio de Sanidad, Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Informe de Posicionamiento Terap\u00e9utico de tolvaptan (Jinarc\u00ae) en poliquistosis renal autos\u00f3mica dominante. IPT, 42\/2022. V1. Available from: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/informesPublicos\/docs\/2022\/IPT_42-2022-Jinarc.pdf."},{"key":"10.1016\/j.nefroe.2024.03.002_bib0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2011.119","article-title":"Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease","volume":"80","author":"Irazabal","year":"2011","journal-title":"Kidney Int"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251424000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251424000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:39:45Z","timestamp":1785253185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251424000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2013251424000609"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2024.03.002","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD)","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2023.01.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}]}}